Dublin, March 08, 2018 (GLOBE NEWSWIRE) -- The "Global Drug Infusion Systems Market: Focus on Products, Application, Competitive Landscape and 57 Countries - Analysis and Forecast (2017-2025)" report has been added to ResearchAndMarkets.com's offering.

The increased prevalence of chronic diseases and the rising geriatric population has led to the high demand for better medicines and facilities. For the continued and improved care of the patients, the drug infusion systems are being extensively used in the hospitals as well as the home care settings.

As per the Arthritis Foundation, the older population in the U.S. affected by arthritis is estimated to grow to 21% by 2040, from the current value of 15%. The rising prevalence of chronic diseases is another factor contributing to the growth of the market. In the recent years, the prevalence of chronic diseases has been increasing irrespective of the age. As per the World Health Organization (WHO), the global prevalence of diabetes increased to 8.5% in adults over the age of 18 years in 2014 from 4.7% in 1980. The prevalence of genetic diseases, and cancer has also witnessed a rise in the recent years.

As per the U.S. FDA an infusion pump is a medical device that delivers controlled amounts of fluids such as nutrients and medication.

The drug infusion systems market includes various infusion systems products including the components such as pumps, accessories and disposables. The market includes several products such as large volume pumps, enteral pumps, syringe pumps, insulin pumps, elastomeric pumps, Patient controlled Analgesia (PCA), ambulatory pumps, and implantable pumps, among many others. These devices are being used for the administration of fluids and medication to a number of diseases, and therapeutic areas such as diabetes, analgesia, nutrition, haematology, oncology and paediatrics.

The market analysis includes an in-depth examination of the key ecosystem players, and the key strategies and developments taking place in this market. Additionally, it includes market dynamics (market drivers, opportunities, and challenges), and industry analysis.

The answers to the following key questions can be derived from this report:

• What are the major market drivers, challenges, and opportunities in the global drug infusion systems market?
• How did the drug infusion systems market evolve, and what is its scope in the future?
• What is the market share of the leading segments, and sub-segments of the global drug infusion systems market in the period 2016-2025?
• How will each segment of the global drug infusion systems market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2025?
• What are the influencing factors that may affect the market share of the key players?
• What are the key developmental strategies implemented by the key players to stand out in this market?
• What is the infusion systems market value in different countries of the world?
• What will be the growth rate of the insulin infusion systems during the forecast period?
• Which product segment is expected to register the highest CAGR for the drug infusion systems market?
• How has the market been segmented on the basis of application? Which application segment has the largest share, and growth rate in the drug infusion systems market?
• How the homecare segment among the end users will grow in the period 2016-2025?
• Which geographical region will contribute to the highest sales of drug infusion systems?

Key Topics Covered:

Executive Summary

1 Market Overview
1.1. Introduction
1.2. Definition and Characterization
1.3. Infusion Systems Application
1.4. Market Size and Growth Potential
1.5. Technology Advancements
1.6. Pricing Analysis
1.7. Recent Product Launches

2 Market Dynamics
2.1. Market Drivers
2.2. Market Challenges
2.3. Market Opportunities

3 Industry Insights
3.1. Regulatory Scenario
3.2. Patent Landscape

4 Competitive Landscape
4.1. Share of Different Strategies
4.2. Porter's Five Force Analysis
4.3. Market Share Analysis

5 Global Drug Infusion Systems Market, By Product
5.1. Introduction & Different Components of a Drug Infusion System
5.2. Market Segment
5.3. Large Volume Infusion Systems
5.4. Patient Controlled Analgesia
5.5. Elastomeric Infusion Pumps
5.6. Insulin Infusion Pumps
5.7. Syringe Infusion Systems
5.8. Implantable Infusion Systems
5.9. Ambulatory Infusion Systems
5.10. Enteral Infusion Systems

6 Global Drug Infusion Systems Market, by Application
6.1. Introduction
6.2. Oncology/Chemotherapy
6.3. Diabetes
6.4. Analgesia
6.5. Nutrition
6.6. Haematology
6.7. Paediatrics
6.8. Other Applications

7 Global Drug Infusion Systems Market, By End User
7.1. Introduction
7.2. Different Types of End Users

8 Global Drug Infusion Systems Market, By Region

9 Company Profiles

• Acromed AG
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton, Dickinson and Company
• Caesarea Medical Electronics Ltd.
• Debiotech S.A.
• Fresenius SE & Co. KGaA
• Halyard Health, Inc.
• ICU Medical Inc.
• IRADIMED CORPORATION
• Insulet Corporation
• Medtronic Public Limited Company

For more information about this report visit https://www.researchandmarkets.com/research/kp9qbb/global_drug?w=12

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Infusions and Injectables 

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.